Deadline: 4 June 2020

Topic:

Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing

Programme:

Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.2: Innovative health and care industry

Funding rate:

EUR 60 million

Status: Closed

Funding rate:

between EUR 10 and 20 million

Topic:
Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing

Who can participate:

Programme:
Horizon 2020 SC1 "Health, demographic change and wellbeing" Priority 1.2: Innovative health and care industry

Consortium:

Status: Open

Total budget:
EUR 60 million

Funding rate:
between EUR 10 and 20 million

Notes:
Scope: - Integrative approaches in human biology and related toxicity pathways to propose and demonstrate scientifically valid means for comprehensive safety assessment of chemicals without resorting to animal testing - Establish the scientific credibility of the approaches for a variety of relevant decision-making contexts and regulatory requirements - Cooperation with complementary initiatives in and outside the EU, including with industry, and Joint research Center (JRC) Impact: - Scientifically sound, practicably implementable non-animal solutions deployable to inform safety assessment of chemicals across sectors - Recognition from regulatory bodies and their engagement to translate results, methods and solutions into safety assessment practice - Reduced use of laboratory animals in safety testing